title: Is continuous venovenous hemofiltration effective against severe acute pancreatitis?
abstract: Our aim was to investigate the efficacy of continuous venovenous hemofiltration (CVVH) in treating severe acute pancreatitis (SAP). A literature search was performed using PubMed (1992-present), and all studies investigating the efficacy of CVVH in treating SAP were included. Four comparative studies and seven case series comprising a total of 354 patients were included. The overall mortality rate of patients receiving CVVH was 20% (55/275). A decreased mortality rate and decreased serum cytokine levels were reported in the CVVH groups in only two studies. The starting time point, substitution fluid flow rate, filter membrane type, hemofilter change interval, anticoagulation, and sustaining times of CVVH varied among the studies, and the impact of these parameters on the efficacy of CVVH was poorly reported. High-volume CVVH, when started early, was demonstrated to be more effective in eliminating cytokines in only one study. After the application of CVVH, the patient conditions started to improve between the 6th and 72nd hours. In conclusion, no solid clinical evidence has proven the efficacy of CVVH in treating SAP. High-volume CVVH that is started early and sustained for at least 72 h may be adopted to investigate the efficacy of CVVH for treating SAP.
authors: Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi, China.
authors: Shiqi
authors: S
authors: Wang
authors: Lei
authors: L
authors: Xu
authors: Xiangying
authors: X
authors: Feng
authors: Shujun
authors: S
authors: Li
authors: Quanxin
authors: Q
authors: Feng
authors: Chaoxu
authors: C
authors: Liu
authors: Xujie
authors: X
authors: Zhang
authors: Qingchuan
authors: Q
authors: Zhao
mesh_terms: D000208:Acute Disease; D015415:Biomarkers / Q000097:blood; D016207:Cytokines / Q000097:blood; D004867:Equipment Design; D005260:Female; D006440:Hemofiltration / Q000009:adverse effects / Q000295:instrumentation / Q000401:mortality; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D008297:Male; D008567:Membranes, Artificial; D010195:Pancreatitis / Q000097:blood / Q000175:diagnosis / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D016207:Cytokines; D018836:Inflammation Mediators; D008567:Membranes, Artificial
keywords: Acute pancreatitis; Hemofiltration; Prognosis